Recently, RAD18 has been ascertained to modulate proliferation, migration, and chemosensitivity of multiple cancers, including rectal cancer [21] and esophageal squamous cell carcinoma [22]. This evidence concerns the gene RAD18 and esophageal squamous cell carcinoma.